Rhabdomyosarcoma With EWSR1::NF2 Gene Fusion: A Case Report Potentially Expanding Its Genetic Spectrum. Read more about Rhabdomyosarcoma With EWSR1::NF2 Gene Fusion: A Case Report Potentially Expanding Its Genetic Spectrum.
Metastatic SQSTM1-NTRK1 fused non-small-cell lung cancer treated with larotrectinib and stereotactic radiosurgery resulting in durable complete response: a case report. Read more about Metastatic SQSTM1-NTRK1 fused non-small-cell lung cancer treated with larotrectinib and stereotactic radiosurgery resulting in durable complete response: a case report.
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial Read more about CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
NTRK Fusion–Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy Read more about NTRK Fusion–Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Cytologic Diagnoses of Lung Adenocarcinoma With Concomitant Metastasis From a Different Primary: A Case Series. Read more about Cytologic Diagnoses of Lung Adenocarcinoma With Concomitant Metastasis From a Different Primary: A Case Series.
Metastatic SQSTM1-NTRK1 fused non-small-cell lung cancer treated with larotrectinib and stereotactic radiosurgery resulting in durable complete response: a case report. Read more about Metastatic SQSTM1-NTRK1 fused non-small-cell lung cancer treated with larotrectinib and stereotactic radiosurgery resulting in durable complete response: a case report.
Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma Read more about Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma
A germline FLT3 variant in aplastic anemia Read more about A germline FLT3 variant in aplastic anemia
Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors Read more about Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors
Tumor gene expression signatures associated with outcome in large B−cell lymphoma treated with CD19-directed CAR T−cell therapy (axicabtagene ciloleucel) Read more about Tumor gene expression signatures associated with outcome in large B−cell lymphoma treated with CD19-directed CAR T−cell therapy (axicabtagene ciloleucel)